⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EVAX News
Evaxion A/S American Depositary Share
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer
globenewswire.com
EVAX
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
globenewswire.com
EVAX
MRK
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
globenewswire.com
EVAX
Evaxion concludes Annual General Meeting
globenewswire.com
EVAX
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
globenewswire.com
EVAX
Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress
globenewswire.com
EVAX
Notice to convene Evaxion’s Annual General Meeting
globenewswire.com
EVAX
Evaxion to present new data at AACR Annual Meeting
globenewswire.com
EVAX
Evaxion announces business update and full year 2025 financial results
globenewswire.com
EVAX
Evaxion plans to file 2025 annual report later today
globenewswire.com
EVAX